[1]
T. T. Purmonen, E. Pänkäläinen, J. H. O. Turunen, C. Asseburg, and J. A. Martikainen, “Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial”, AO, vol. 50, no. 3, pp. 344–352, Apr. 2011.